Science & Research
GeoVax CEO David Dodd to Discuss MVA-Based Vaccine Platforms for Broader Infectious Disease Preparedness in Tribe Public Webinar
GeoVax Labs CEO David Dodd will participate in a Tribe Public webinar on May 28, 2026, to discuss the need for platform-based vaccine technologies to address multiple viral threats like Ebola, Marburg, mpox, and hantavirus, emphasizing the limitations of single-threat preparedness.
TransCode Therapeutics Initiates Phase 2a Trial of TTX-MC138 in Colorectal Cancer Patients with Minimal Residual Disease
TransCode Therapeutics has started a Phase 2a trial evaluating TTX-MC138 in colorectal cancer patients with minimal residual disease, aiming to reduce recurrence risk in a high-risk population.
Tonix Pharmaceuticals Publishes Phase 1 TNX-1500 Data, Paving Way for Kidney Transplant Study
Tonix Pharmaceuticals announced publication of Phase 1 data for TNX-1500, an anti-CD40L monoclonal antibody, showing favorable safety and pharmacodynamics, supporting advancement to a Phase 2 kidney transplant rejection study.
VolitionRx Reports Progress in Diagnostics Pipeline, Including Feline Lymphoma Manuscript Submission Tied to $5M Milestone
VolitionRx provided a corporate update highlighting clinical and commercial progress, including a feline lymphoma manuscript submission linked to a $5 million milestone payment and licensing discussions with over a dozen global diagnostic companies.
Study Reveals Widespread Sexual Difficulties Among Young Cancer Survivors
A new study from Karolinska Institutet finds that sexual problems are common among young adults after cancer treatment, with severity varying by cancer type and treatment intensity.
Search Minerals Launches 2026 Rare Earth Exploration Program in Labrador to Advance Towards Production
Search Minerals Inc. has initiated its 2026 critical rare earth element exploration program in southeastern Labrador, focusing on resource expansion and bulk sampling to support its demonstration plant and patented extraction process.
Regentis Biomaterials Targets $3 Billion U.S. Knee Cartilage Repair Market with GelrinC
Regentis Biomaterials’ GelrinC offers a potential first-in-class, off-the-shelf solution for knee cartilage repair, with Phase III trial underway and CE Mark approval in Europe.
Astrotech Launches Lunar Infrastructure Initiative Targeting Quantum Computing and Resource Development
Astrotech Corporation (NASDAQ: ASTC) announced a strategic initiative focused on lunar resource development, autonomous industrial infrastructure, and potential Moon-based semiconductor and quantum computing manufacturing, leveraging its spaceflight heritage and aligning with NASA's Artemis and Commercial Lunar Payload Services programs.
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Solution for Knee Cartilage Repair, Targeting a 472,500-Procedure Gap
Regentis Biomaterials is developing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could fill a market gap as no approved off-the-shelf regenerative solution exists in the U.S., with a pivotal FDA trial now over 50% enrolled and a new manufacturing process boosting yield by 400%.
Brain Cell Division Errors May Unlock New Cancer Treatments, Study Finds
Researchers at the University of Virginia have discovered that errors in brain cell division during development could trigger cancer and developmental disorders, offering new pathways for treatment and prevention.
Jeff Bezos Casts Doubt on Timelines for Orbital Data Centers
Amazon founder Jeff Bezos questions the accuracy of rival companies' timelines for establishing data centers in space, highlighting uncertainties in the emerging orbital data center industry.
MAX Power Mining Identifies High-Priority Drill Targets at Saskatchewan Natural Hydrogen Project
MAX Power Mining advances commercial validation of its natural hydrogen system in Saskatchewan by identifying high-priority drill targets from 3D seismic data, planning a multi-well program to evaluate key commercial parameters.
Scientists Make Progress on Blood Test for Early Lung Cancer Detection
Researchers are developing a blood test that could identify individuals at high risk for lung cancer, addressing the limitations of current screening focused solely on smoking history.
SureNano Science Targets Obesity Market with Novel GLP-1 Therapy GEP-44
SureNano Science Ltd. is advancing a differentiated GLP-1-based therapy, GEP-44, aiming to compete in the rapidly growing obesity and metabolic disease market dominated by blockbusters like Ozempic and Wegovy.
Graphene Quantum Dots Show Promise in Targeting Parkinson's-Related Protein Clumping
A new study reveals that graphene quantum dots can interfere with the aggregation of misfolded proteins linked to Parkinson's disease, offering a potential new direction for therapeutic exploration.
Western Star Resources Mobilizes Field Team to Rowland Tungsten Property for Modern Exploration Program
Western Star Resources has launched the first modern exploration program at its past-producing Rowland Tungsten Property in Nevada, using drone geophysics and geochemistry to define drill-ready targets by the end of 2026.
Nevada Organic Phosphate Reports Encouraging Preliminary Drill Results at Murdock Mountain Project
Nevada Organic Phosphate Inc. announced preliminary drill results from its Murdock Mountain property, intersecting 39 meters of target stratigraphy, highlighting the potential of its large-scale organic sedimentary phosphate project in Nevada.
UNC Researchers Develop More Targeted Immunotherapy for Acute Myeloid Leukemia
Scientists at the University of North Carolina have engineered immune cells that selectively destroy acute myeloid leukemia while sparing healthy blood tissue, potentially expanding treatment options for patients.
Telomir Pharmaceuticals Reports Preclinical Data Showing Telomir-Zn Benefits in Wilson’s Disease Model
Telomir Pharmaceuticals announced peer-reviewed preclinical data demonstrating that Telomir-Zn improved survival and reduced oxidative stress and copper burden in a Wilson’s disease model, expanding the drug’s potential beyond its lead cancer program.
Rail Vision Subsidiary Achieves Quantum Error Correction Milestone Using Google Quantum AI Dataset
Rail Vision Ltd.'s majority-owned subsidiary, Quantum Transportation Ltd., has successfully integrated Google Quantum AI's experimental surface-code dataset into its quantum error correction pipeline, advancing quantum decoding technology and reducing technical risk.
GeoVax Highlights MVA Platform's Potential Amid Bundibugyo Ebola Outbreak
GeoVax Labs comments on the WHO-declared PHEIC for Bundibugyo Ebola, emphasizing the need for flexible vaccine platforms like its MVA-based technology to address emerging viral threats.
Quantum BioPharma Hits Midpoint Enrollment in MS Imaging Study, Signaling Potential for Novel Diagnostic and Therapeutic Advances
Quantum BioPharma announced that its collaborative MS imaging study with Massachusetts General Hospital has reached midpoint enrollment, with preliminary PET tracer data showing promise for detecting active and gray matter lesions, which could accelerate development of its investigational MS therapy Lucid-MS.
American Heart Association Releases 2026 Dietary Guidance: 9 Steps for Heart-Healthy Eating
The American Heart Association's new dietary guidance outlines nine evidence-based steps to improve cardiovascular health through lifelong healthy eating patterns, addressing the high prevalence of unhealthy diets among U.S. adults and children.
Lantern Pharma Gains FDA Support for HARMONIC Trial Amendments in Never-Smoker Lung Cancer
Lantern Pharma announced FDA no objections to protocol amendments for its Phase 2 HARMONIC trial of LP-300 in never-smokers with advanced NSCLC, focusing on a specific EGFR mutation subgroup.
GeoVax Raises $3 Million in Private Placement to Fund Vaccine Development
GeoVax Labs secures $3 million through a private placement with institutional investors to advance its mpox/smallpox vaccine and other pipeline programs.
Oragenics Advances Phase IIa Concussion Trial, Eyes CNS Device Licensing
Oragenics provided a shareholder update on its Phase IIa trial of ONP-002 for concussion in Australia, plans for U.S. regulatory meetings, and a letter of intent to license a complementary CNS medical device.
NanoViricides Highlights Broad-Spectrum Antiviral NV-387 Amid Ebola Outbreak
NanoViricides underscores the potential of its oral drug candidate NV-387 as a pandemic preparedness tool amid the ongoing Bundibugyo Ebola outbreak in the Democratic Republic of Congo and Uganda.
Quantum BioPharma Reaches Midpoint Enrollment in MS Imaging Study, Showing Encouraging Early Data
Quantum BioPharma announced that patient enrollment in its multiple sclerosis imaging study with Massachusetts General Hospital has reached 50%, with preliminary PET imaging data showing promising signals in acute MS lesions and potential sensitivity to gray matter lesions, which could accelerate development of MS therapies including its candidate Lucid-MS.
Global Collaboration Urged to Reduce Heart Risks in Children with Kawasaki Disease
A new science advisory from the American Heart Association emphasizes that international collaboration in research, diagnosis, and care is essential to reduce the risk of serious heart conditions in children with Kawasaki disease worldwide.
New Catalyst Could Slash Hydrogen Production Costs, Boosting Renewable Energy Storage
Scientists have developed a more efficient catalyst for producing hydrogen from water, potentially reducing costs and advancing renewable energy storage, while companies like MAX Power Mining Corp. work toward commercial extraction.